Cleveland Clinic study assesses psychomotor recovery
CHIP Clinic's goals: Research, preventive care
Study assesses outcomes of therapies with novel agents
Autologous anti-CD19 agent produces impressive survival improvements
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Interim results of phase 2 trial are promising
Predictive tool should help in treatment decisions
Method can eliminate need for liver biopsies in significant number of patients
Significant reduction in risk for vision loss and disease progression
Brillouin imaging, corneal cross-linking could aid identification and management of keratoconus and postoperative ectasia
Prospective review of parameters improves plan consistency, saves time
Advertisement
Advertisement